LT-1002 / LTT Bio-Pharma, Chong Kun Dang 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  iSONEP (sonepcizumab) / Pfizer, Lpath, LT-1002 - LTT Bio / Pharma, Chong Kun Dang
    Journal:  Ion Binding Properties of a Naturally Occurring Metalloantibody. (Pubmed Central) -  Apr 23, 2020   
    To test this hypothesis, we engineered, expressed, and purified a Fab fragment consisting of naïve murine germline-encoded light and heavy chain genes from which LT1002 is derived and observed that it binds Ca in solution. We propose that LT1002 is representative of a class of naturally occurring metalloantibodies that are evolutionarily conserved across diverse mammalian genomes.